Novel Oral Anticoagulants Drugs Market to Signify Strong Growth by 2023-2029

The Novel Oral Anticoagulants Drugs Market is anticipated to grow at a significant CAGR during the forecast period. Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. These drugs are majorly used for high risk of blood clots in various medical conditions, such as atrial fibrillation, deep vein thrombosis, myocardial infarction, pulmonary embolism, stroke, and others.

The major factors that are fuelling the growth of the global novel oral anticoagulants drugs market during the forecast period include increasing prevalence of venous thromboembolism (VTE) and cardiovascular disorders, rising awareness of NOACs in the developing region and growing adoption of novel oral anticoagulants (NOACs). Moreover, an increase in the number of obese and elderly people, higher unmet needs, and a surge in demand for novel therapeutics further support the market growth.

The global novel oral anticoagulants drugs market analysis includes some of the key market players such as Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, and Daiichi Sankyo Company, among others.

To Request a Sample of our Report on Novel Oral Anticoagulants Drugs Market:  https://www.omrglobal.com/request-sample/novel-oral-anticoagulants-drugs-market

Market Coverage

  • The market number available for – 2022-2030
  • Base year- 2022
  • Forecast period- 2023-2030
  • Segment Covered
  • Regions Covered- Globally
  • Competitive Landscape: Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, and Daiichi Sankyo Company, among others.

Novel Oral Anticoagulants Drugs Market by Segment

By Type

  • Direct Thrombin Inhibitor
  • Factor Xa Inhibitors

By Application

  • Hospital
  • Drugs Stores
  • Other

A full Report of Novel Oral Anticoagulants Drugs Market is Available at:  https://www.omrglobal.com/industry-reports/novel-oral-anticoagulants-drugs-market

Novel Oral Anticoagulants Drugs Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • South Korea
  • Rest of APAC

Rest of the World

Reasons to buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404